Paper Details
- Home
- Paper Details
Effects of nateglinide and repaglinide administered intracerebroventricularly on the CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Author: JungJun-Sub, KimChea-Ha, KimSu-Jin, KimSung-Su, LimSu-Min, ParkSoo-Hyun, SimYun-Beom, SuhHong-Won
Original Abstract of the Article :
Meglitinides (nateglinide and repaglinide) are widely used oral drugs for the treatment of type II diabetes mellitus. In the present study, the effects of meglinitides administered supraspinally on kainic acid (KA)-induced hippocampal neuronal cell death and hyperglycemia were studied in ICR mice. M...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.brainresbull.2014.02.003
データ提供:米国国立医学図書館(NLM)
Meglitinides: A Potential New Weapon Against Brain Damage?
The intricate workings of the brain are like a vast desert, with neurons as its shimmering oases. This research explores the potential of meglitinides, a class of drugs used to treat diabetes, to protect these vital oases from damage caused by kainic acid, a powerful neurotoxin.
The study used a carefully designed experiment in mice to assess the effects of two meglitinides, nateglinide and repaglinide, on hippocampal neuronal cell death and hyperglycemia induced by kainic acid. The researchers found that repaglinide, when administered directly to the brain, successfully protected against kainic acid-induced neuronal death and hyperglycemia. However, nateglinide did not have the same protective effect. This suggests that repaglinide may have a specific neuroprotective mechanism that is not shared by nateglinide. It's like the difference between a refreshing oasis in the desert and a mirage - both appear promising, but only one can truly quench your thirst.
The Promise of Repaglinide as a Neuroprotective Agent
This research sheds light on the potential of repaglinide as a neuroprotective agent. The findings suggest that repaglinide may have the ability to protect against brain damage, opening new avenues for treating neurological disorders.
Implications for Brain Health
This research offers a glimmer of hope in the vast desert of brain disorders. The potential of repaglinide to protect against brain damage could lead to significant advancements in treating neurological conditions.
Dr. Camel's Conclusion
This research provides a fascinating glimpse into the potential of meglitinides, a class of drugs used to treat diabetes, to protect the brain's vital neurons from damage. The study highlights the intriguing possibility of repaglinide as a neuroprotective agent, offering hope for the treatment of neurological disorders and providing a new oasis in the desert of brain health.
Date :
- Date Completed 2014-12-28
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.